drugset
drugset / Trial / NCT03849339

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition

NCT03849339 ↗

Phase 1 Unknown 20 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the clinical trail is to evaluate the pharmacokinetics and safety/tolerability after oral administration of CKD-387 and D635 under fed condition in healthy adults.

Timeline

Start
2019-01-28
Primary completion
2019-02-21
Completion
2019-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-387 Unknown — Oral
Subject D635 Unknown — Oral

Indications

type 2 diabetes mellitus